Hong Kong Stock IPO: Suzhou Zijin Biological submits listing application to Hong Kong Stock Exchange.

Suzhou Zelgen Biopharmaceutical Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with China International Capital Corporation as the exclusive sponsor.